Defilade Capital Management, L.P.
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 13, 2026), Defilade Capital Management, L.P. reported 33 stock positions worth $737.7 million. Its top holding was Pfizer (PFE) at 7.4% of the portfolio, followed by Abbvie (ABBV, 7.1%) and Novartis AG-Sponsored ADR (NVS, 6.8%).
- Most Recent 13F
- Q2 2026
- Location
- EMERYVILLE, CA
- CIK
- 0002088557
- Portfolio Value
- $737.7M (Q4 2025)
- SEC Filing
- 0002088557-26-000002 ↗ filed Feb 13, 2026
Holdings Value
Holdings 33 stocks · $737.7M
| PFE Pfizer Inc. | 7.44% | 2,203,504 | $54.9M | — |
| ABBV Abbvie Inc. | 7.05% | 227,669 | $52.0M | — |
| NVS Novartis AG-Sponsored ADR | 6.78% | 362,816 | $50.0M | — |
| ICUI Icu Medical Inc. | 6.59% | 340,745 | $48.6M | — |
| PACS Pacs Group Inc. | 5.96% | 1,145,485 | $44.0M | — |
| LLY Eli Lilly & Co. | 4.65% | 31,950 | $34.3M | — |
| STE Steris PLC | 4.65% | 135,307 | $34.3M | — |
| OLMA Olema Pharmaceuticals Inc. | 4.18% | 1,234,634 | $30.9M | — |
| RVMD Revolution Medicines Inc. | 3.92% | 363,454 | $28.9M | — |
| BIIB Biogen Inc. | 3.86% | 161,992 | $28.5M | — |
| NUVL Nuvalent Inc. Class A | 3.67% | 269,043 | $27.1M | — |
| ISRG Intuitive Surgical Inc. | 3.51% | 45,662 | $25.9M | — |
| HSIC Henry Schein Inc. | 3.28% | 320,422 | $24.2M | — |
| GMED Globus Medical Inc. Class A | 3.16% | 267,212 | $23.3M | — |
| XNCR Xencor Inc. | 2.94% | 1,414,755 | $21.7M | — |
| COGT Cogent Biosciences Inc. | 2.74% | 568,619 | $20.2M | — |
| ALGN Align Technology Inc. | 2.71% | 128,060 | $20.0M | — |
| ASND Ascendis Pharma A/S | 2.48% | 85,694 | $18.3M | — |
| DXCM Dexcom Inc. | 2.20% | 244,881 | $16.3M | — |
| BDX Becton Dickinson and Co. | 2.14% | 81,207 | $15.8M | — |
| ATRC Atricure Inc. | 2.13% | 397,636 | $15.7M | — |
| LIVN Livanova PLC | 2.01% | 241,413 | $14.9M | — |
| ATEC Alphatec Holdings Inc. | 1.79% | 626,754 | $13.2M | — |
| DNLI Denali Therapeutics Inc. | 1.47% | 656,713 | $10.8M | — |
| GKOS Glaukos Corp. | 1.40% | 91,703 | $10.4M | — |
| RXST Rxsight Inc. | 1.29% | 913,090 | $9.5M | — |
| ELAN Elanco Animal Health Inc. | 1.23% | 401,283 | $9.1M | — |
| INSM Insmed Inc. | 1.18% | 50,000 | $8.7M | — |
| OCUL Ocular Therapeutix Inc. | 1.12% | 681,663 | $8.3M | — |
| TFX Teleflex Inc. | 0.71% | 42,850 | $5.2M | — |
| ELDN Eledon Pharmaceuticals Inc. | 0.67% | 3,290,450 | $5.0M | — |
| CNMD Conmed Corp. | 0.57% | 104,129 | $4.2M | — |
| EVMN Evommune Inc. | 0.50% | 215,418 | $3.7M | — |
Portfolio Sells Q4 2025
No earlier filing to compare with.
Portfolio Buys Q4 2025
No earlier filing to compare with.